相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor
Ciara M. Kelly et al.
INVESTIGATIONAL NEW DRUGS (2019)
MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway
Jin Gao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
The FGFR1 V561M Gatekeeper Mutation Drives AZD4547 Resistance through STAT3 Activation and EMT
Molly R. Ryan et al.
MOLECULAR CANCER RESEARCH (2019)
FEZF1-AS1 is a key regulator of cell cycle, epithelial-mesenchymal transition and Wnt/β-catenin signaling in nasopharyngeal carcinoma cells
Yunzhou Cheng
BIOSCIENCE REPORTS (2019)
Long noncoding RNA HOTAIR knockdown inhibits autophagy and epithelial-mesenchymal transition through the Wnt signaling pathway in radioresistant human cervical cancer HeLa cells
Xinggang Guo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer
Tingting Lu et al.
CANCER LETTERS (2018)
Histologic Lung Cancer Incidence Rates and Trends Vary by Race/Ethnicity and Residential County
Keisha A. Houston et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
BGJ398 for FGFR-altered advanced cholangiocarcinoma
Judith A. Gilbert
LANCET ONCOLOGY (2018)
miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer
Ulrich Baumgartner et al.
MOLECULAR CANCER (2018)
FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer
Kaixuan Wang et al.
ONCOGENE (2018)
MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7
Yuan-Yuan Ye et al.
CELL DEATH & DISEASE (2018)
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations
Sumanta K. Pal et al.
CANCER DISCOVERY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
LY2874455 potently inhibits FGFR gatekeeper mutants and overcomes mutation-based resistance
Daichao Wu et al.
CHEMICAL COMMUNICATIONS (2018)
Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models
Daniela Dettori et al.
MOLECULAR THERAPY (2018)
TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells
Mao Yang et al.
BREAST CANCER RESEARCH (2018)
miR-127 promotes EMT and stem-like traits in lung cancer through a feed-forward regulatory loop
L. Shi et al.
ONCOGENE (2017)
MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway
Qiuran Xu et al.
MOLECULAR CANCER (2017)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer
Michael Michael et al.
TARGETED ONCOLOGY (2017)
Down-regulation of miR-214 reverses erlotinib resistance in non-small-cell lung cancer through up-regulating LHX6 expression
Jinrong Liao et al.
SCIENTIFIC REPORTS (2017)
Mechanisms of Primary Drug Resistance in FGFR1-Amplified Lung Cancer
Florian Malchers et al.
CLINICAL CANCER RESEARCH (2017)
A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers
Paul K. Paik et al.
CLINICAL CANCER RESEARCH (2017)
The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing
Teresa Helsten et al.
CLINICAL CANCER RESEARCH (2016)
Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1
P. Phatak et al.
ONCOGENE (2016)
Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression
H. Kotani et al.
ONCOGENE (2016)
MiR-214 Attenuates Osteogenic Differentiation of Mesenchymal Stem Cells via Targeting FGFR1
Lei Yang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
miR-296 inhibits proliferation and induces apoptosis by targeting FGFR1 in human hepatocellular carcinoma
Liyan Wang et al.
FEBS LETTERS (2016)
Amplification of FGFR1 gene and expression of FGFR1 protein is found in different histological types of lung carcinoma
Vitor Sousa et al.
VIRCHOWS ARCHIV (2016)
Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for Treatment of Lung Cancer and HNSCC
Katherine R. Singleton et al.
CANCER RESEARCH (2015)
miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway
Chenyang Zhao et al.
RNA BIOLOGY (2015)
Targeting the Wnt-Regulatory Protein CTNNBIP1 by microRNA-214 Enhances the Stemness and Self-Renewal of Cancer Stem-Like Cells in Lung Adenocarcinomas
Wei Qi et al.
STEM CELLS (2015)
The Regulatory Role of MicroRNAs in EMT and Cancer
Apostolos Zaravinos
JOURNAL OF ONCOLOGY (2015)
Identification of MicroRNA-214 as a Negative Regulator of Colorectal Cancer Liver Metastasis by Way of Regulation of Fibroblast Growth Factor Receptor 1 Expression
Dong-liang Chen et al.
HEPATOLOGY (2014)
Fibroblast growth factor receptor 1 (FGFR1) amplification is a potential therapeutic target in small-cell lung cancer
Anne M. Schultheis et al.
MODERN PATHOLOGY (2014)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
MicroRNAs in cancer: biomarkers, functions and therapy
Josie Hayes et al.
TRENDS IN MOLECULAR MEDICINE (2014)
The FGFR1 inhibitor PD173074 induces mesenchymal-epithelial transition through the transcription factor AP-1
P. T. Nguyen et al.
BRITISH JOURNAL OF CANCER (2013)
STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells
H-Y Lin et al.
BRITISH JOURNAL OF CANCER (2013)
Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer
Hye Ryun Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK
Keitaro Yamane et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
miR-20a Encoded by the miR-17-92 Cluster Increases the Metastatic Potential of Osteosarcoma Cells by Regulating Fas Expression
Gangxiong Huang et al.
CANCER RESEARCH (2012)
AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family
Paul R. Gavine et al.
CANCER RESEARCH (2012)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
Searching for the 'melano-miRs': miR-214 drives melanoma metastasis
Menashe Bar-Eli
EMBO JOURNAL (2011)
microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C
Elisa Penna et al.
EMBO JOURNAL (2011)
Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
Amit Dutt et al.
PLOS ONE (2011)
FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
Nicholas Turner et al.
CANCER RESEARCH (2010)
Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
Jonathan Weiss et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Fibroblast growth factor signalling: from development to cancer
Nicholas Turner et al.
NATURE REVIEWS CANCER (2010)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Kornelia Polyak et al.
NATURE REVIEWS CANCER (2009)
Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition
Victor D. Acevedo et al.
CANCER CELL (2007)
Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitor
Tammie C. Yeh et al.
CLINICAL CANCER RESEARCH (2007)
Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate
Alex S. Flynt et al.
NATURE GENETICS (2007)
Recurrent FGFR 1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC)
Kolja Freier et al.
ORAL ONCOLOGY (2007)
FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas
Jorge Sergio Reis-Filho et al.
CLINICAL CANCER RESEARCH (2006)
MicroRNA functions in animal development and human disease
I Alvarez-Garcia et al.
DEVELOPMENT (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
分享论文
